Substance

ID:950

Names and Identifiers
Brand Name
AlerylAller-MedAllerdrylAllergan BAllergevalAllerginaSominexSyntodrilDihidralDiphenDrylistanHistaxinNervine Nighttime Sleep-AidNytol QuickcapsBenachlorBenaponBenylinBenzhydroaminaDifedrylDifenhydraminAllergicalAmbodrylAmidrylAntistominumAntitussiveBanophen CapletsUnisom Sleepgels Maximum StrengthVenaVicks Formula 44AlledrylHyrexinNovaminaRigidilSleep-Eze DTorinalTwilite CapletsDiabenylDiabylenDibondrinDimedrylDiphen CoughEtanautineAllermax CapletsBeldinBenadryl Preservative FreeBenzhydraminumBenzhydrilBenzhydrylNausenNytol QuickgelsRestaminSiladrylAllerginGenahistHyadrineHydramineMephadrylDiphenhistDiphenhist CaptabsDormarex 2DryistanSyntedrilDylamonDebendrinDermistinaDermodrinSoverinDibenilDiphantineProbedrylRigidylBenzhydramineSilphenSleep-Eze D Extra StrengthCompozBenadrylBenodinDimedrolBenodineIbiodralMedidrylBagodrylBanophenBelixDibendrinBen-AllerginDifenidraminaBenylanBenzantineBetraminDabylenDesentolAllergivalAntominAutominBaramineBenaBenadrinBenadryl Allergy
Synonyms
Diphenhydramine HclDiphenhydramine BaseDiphenylhydramineDiphenhydramine SalicylateDiphenhydramine
IUPAC Traditional name
diphenhydramine
IUPAC name
[2-(diphenylmethoxy)ethyl]dimethylamine
Registration numbers
CAS Number
PubChem CID
PubChem SID
Properties
Physical Property
Hydrophobicity(logP)
3.27 [HANSCH,C ET AL. (1995)]
Solubility
3.06 mg/mL at 37 oC [BEILSTEIN]
Molecule Details
Drug Groups
approved
Description
A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
Indication
For the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite.
Pharmacology
Diphenhydramine is an antihistamine of the ethanolamine class. Ethanolamine antihistamines have significant antimuscarinic activity and produce marked sedation in most patients. In addition to the usual allergic symptoms, the drug also treats irritant cough and nausea, vomiting, and vertigo associated with motion sickness. It also is used commonly to treat drug-induced extrapyramidal symptoms as well as to treat mild cases of Parkinson's disease. Rather than preventing the release of histamine, as do cromolyn and nedocromil, diphenhydramine competes with free histamine for binding at HA-receptor sites. Diphenhydramine competitively antagonizes the effects of histamine on HA-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Ethanolamine derivatives have greater anticholinergic activity than do other antihistamines, which probably accounts for the antidyskinetic action of diphenhydramine. This anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown.
Toxicity
LD50=500 mg/kg (orally in rats). Considerable overdosage can lead to myocardial infarction (heart attack), serious ventricular dysrhythmias, coma and death.
Affected Organisms
Humans and other mammals
Biotransformation
Hepatic and renal
Absorption
Quickly absorbed with maximum activity occurring in approximately one hour.
Half Life
1-4 hours
Protein Binding
98 to 99%
Elimination
Little, if any, is excreted unchanged in the urine; most appears as the degradation products of metabolic transformation in the liver, which are almost completely excreted within 24 hours.
References
• Raphael GD, Angello JT, Wu MM, Druce HM: Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006 Apr;96(4):606-14. [Pubmed]
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
• Raphael GD, Angello JT, Wu MM, Druce HM: Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006 Apr;96(4):606-14. Pubmed